BR112015008285A2 - processo para preparar uma formulação farmacêutica particulada - Google Patents

processo para preparar uma formulação farmacêutica particulada

Info

Publication number
BR112015008285A2
BR112015008285A2 BR112015008285A BR112015008285A BR112015008285A2 BR 112015008285 A2 BR112015008285 A2 BR 112015008285A2 BR 112015008285 A BR112015008285 A BR 112015008285A BR 112015008285 A BR112015008285 A BR 112015008285A BR 112015008285 A2 BR112015008285 A2 BR 112015008285A2
Authority
BR
Brazil
Prior art keywords
particles
preparing
particulate pharmaceutical
pharmaceutical formulation
solvent
Prior art date
Application number
BR112015008285A
Other languages
English (en)
Other versions
BR112015008285B1 (pt
Inventor
To Daniel
Capece Maxx
N Dave Rajesh
Original Assignee
New Jersey Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Jersey Inst Technology filed Critical New Jersey Inst Technology
Publication of BR112015008285A2 publication Critical patent/BR112015008285A2/pt
Publication of BR112015008285B1 publication Critical patent/BR112015008285B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1 / 1 resumo “processo para preparar uma formulaã‡ãƒo farmacãšutica particulada” a presente invenã§ã£o ã© um mã©todo sem solvente para produzir ingrediente farmaceuticamente ativo revestido com polã­mero que tem o sabor mascarado e pode ser liberado em um tempo relativamente curto. o processo emprega vibraã§ãµes de alta energia ou misturaã§ã£o acãºstica de partã­culas api, partã­culas de material de revestimento solãºveis em ã¡gua e partã­culas de polã­mero hidrofã³bico, com ou sem o uso de outros pã³s farmaceuticamente relevantes como meio. adicionalmente o mã©todo ã© capaz de produzir partã­culas de droga revestidas individualmente sem aglomeraã§ã£o ou os longos tempos de secagem associados com mã©todos de revestimento com base em solvente.
BR112015008285-8A 2012-10-15 2013-10-09 Processo para preparar uma formulação farmacêutica particulada BR112015008285B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/651,977 US9107851B2 (en) 2012-10-15 2012-10-15 Solventless mixing process for coating pharmaceutical ingredients
US13/651,977 2012-10-15
PCT/US2013/064058 WO2014062444A1 (en) 2012-10-15 2013-10-09 Solventless mixing process for coating pharmaceutical ingredients

Publications (2)

Publication Number Publication Date
BR112015008285A2 true BR112015008285A2 (pt) 2017-07-04
BR112015008285B1 BR112015008285B1 (pt) 2022-11-16

Family

ID=49474713

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015008285-8A BR112015008285B1 (pt) 2012-10-15 2013-10-09 Processo para preparar uma formulação farmacêutica particulada

Country Status (16)

Country Link
US (1) US9107851B2 (pt)
EP (1) EP2906205B1 (pt)
JP (1) JP6159504B2 (pt)
CN (1) CN104853751B (pt)
AR (1) AR093013A1 (pt)
BR (1) BR112015008285B1 (pt)
CY (1) CY1121241T1 (pt)
DK (1) DK2906205T3 (pt)
ES (1) ES2688889T3 (pt)
HR (1) HRP20181463T1 (pt)
HU (1) HUE039772T2 (pt)
PL (1) PL2906205T3 (pt)
PT (1) PT2906205T (pt)
RS (1) RS57918B1 (pt)
SI (1) SI2906205T1 (pt)
WO (1) WO2014062444A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9755235B2 (en) 2014-07-17 2017-09-05 Ada Technologies, Inc. Extreme long life, high energy density batteries and method of making and using the same
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
US10217571B2 (en) 2015-05-21 2019-02-26 Ada Technologies, Inc. High energy density hybrid pseudocapacitors and method of making and using the same
US11996564B2 (en) 2015-06-01 2024-05-28 Forge Nano Inc. Nano-engineered coatings for anode active materials, cathode active materials, and solid-state electrolytes and methods of making batteries containing nano-engineered coatings
WO2017023797A1 (en) 2015-07-31 2017-02-09 Ada Technologies, Inc. High energy and power electrochemical device and method of making and using same
JP7069538B2 (ja) * 2016-12-05 2022-05-18 マルボシ酢株式会社 食酢含有飲料組成物
US11024846B2 (en) 2017-03-23 2021-06-01 Ada Technologies, Inc. High energy/power density, long cycle life, safe lithium-ion battery capable of long-term deep discharge/storage near zero volt and method of making and using the same
WO2019009335A1 (ja) * 2017-07-04 2019-01-10 村上　正裕 微粒子の製造方法及び微粒子
AU2020225818A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
EP3927314B1 (en) * 2019-02-22 2023-08-23 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
CA3129395A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
US20210009767A1 (en) * 2019-07-11 2021-01-14 International Flavors & Fragrances Inc. Solventless particle coating via acoustic mixing
MX2023001004A (es) * 2020-07-31 2023-03-01 Catalent Uk Swindon Zydis Ltd Composiciones farmaceuticas que comprenden un ingrediente farmaceutico activo (api) recubierto.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628945A (en) 1992-08-03 1997-05-13 Riman; Richard E. Multicomponent powder mixing process and compositions produced thereby
WO1994015374A1 (en) * 1992-12-25 1994-07-07 Tdk Corporation Lithium secondary cell
US5769917A (en) * 1996-12-09 1998-06-23 Belko; William C. Process for producing low shrink ceramic bodies
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
DE10062176A1 (de) * 2000-12-14 2002-07-04 Wacker Polymer Systems Gmbh Polyvinylacetal-gepfropfte Polymerisate
US8163114B2 (en) 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
DE102004059792A1 (de) * 2004-12-10 2006-06-14 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Nukleinsäure-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
US20060210694A1 (en) * 2005-03-18 2006-09-21 Chappell Rulon A Anti-caking agents and methods
CA2617190C (en) 2005-08-03 2017-07-18 The University Of Western Ontario Direct coating solid dosage forms using powdered materials
EP2570120B1 (en) 2010-06-08 2017-10-25 Kobe Gakuin Educational Foundation Coated particle and method for producing coated particle
GB201205632D0 (en) 2012-03-30 2012-05-16 Vectura Ltd Method and apparatus
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them

Also Published As

Publication number Publication date
AR093013A1 (es) 2015-05-13
SI2906205T1 (sl) 2018-12-31
PT2906205T (pt) 2018-11-07
JP6159504B2 (ja) 2017-07-05
BR112015008285B1 (pt) 2022-11-16
DK2906205T3 (en) 2018-09-24
WO2014062444A1 (en) 2014-04-24
ES2688889T3 (es) 2018-11-07
US9107851B2 (en) 2015-08-18
HUE039772T2 (hu) 2019-02-28
US20140106059A1 (en) 2014-04-17
CY1121241T1 (el) 2020-05-29
JP2015533162A (ja) 2015-11-19
EP2906205B1 (en) 2018-06-13
HRP20181463T1 (hr) 2018-12-14
RS57918B1 (sr) 2019-01-31
EP2906205A1 (en) 2015-08-19
CN104853751A (zh) 2015-08-19
PL2906205T3 (pl) 2019-03-29
CN104853751B (zh) 2018-06-22

Similar Documents

Publication Publication Date Title
BR112015008285A2 (pt) processo para preparar uma formulação farmacêutica particulada
AU2018253545A1 (en) Microcrystalline diketopiperazine compositions and methods
BR112012023638A2 (pt) Sistema de entrega, composição cosmética, farmacêutica e/ou alimentar e uso da composição cosmética, farmacêutica e/ou alimentar
CO6660512A2 (es) Proceso para fabricar composiciones hemostáticas secas y estables
BRPI0921158A2 (pt) Sistema acústico em gesso de camadas múltiplas
BR112013018402A2 (pt) sistema de bio-refinaria, componentes para o mesmo, processos de uso, e produtos derivados do mesmo
BR112012030818A2 (pt) "derivados de ácido c-3 betulínico modificado como inibidores da maturação do hiv"
MX2015012433A (es) Matriz de microestructura para suministro de agentes activos.
BR112014004460A2 (pt) material polimérico para um recipiente isolado
BR112013029422A2 (pt) cápsulas núcleo-revestimento
BR112012006635B8 (pt) composição que compreende partículas de tamanho micro de fosfato de cálcio uniformes, rígidas, esféricas, nanoporosas e método para combinar e separar o solvente não aquoso das referidas partículas
CL2007002969A1 (es) Procedimiento para producir producto poroso en polvo a partir de un producto inicial pulverulento y/o viscoso que comprende llevar el producto inicial a un estado viscoso, disminuir viscosidad sin cambiar % de materia seca, simultaneamente iniciar po
BR112015008284A2 (pt) processo para preparar uma formulação farmacêutica particulada de gosto mascarado
AR070219A1 (es) Revestimientos hidrofobos
BR112014009438A2 (pt) composição farmacêutica para administração oral, e, método de preparação da composição farmacêutica para administração oral
RS54584B1 (en) 15-HEPE PREPARATIONS AND PROCEDURES FOR THEIR USE
UA112540C2 (uk) Плівкова лікарська форма, яка містить вільну основу силденафілу, і спосіб її отримання
BR112018010743A2 (pt) ?método para fabricação de um pó farmacêutico formulado, e, pó farmacêutico formulado?
BR112014012711A8 (pt) preservativo revestido
BR112014003431A2 (pt) anticorpo, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, agente farmacêutico, uso do anticorpo, método de tratamento de um indivíduo que tem câncer e método de aumento de tempo para recorrência de tumor
BR112013022431A2 (pt) derivado de polissacarídeo, forma de dosagem, processo para preparar uma forma de dosagem e uso de um derivado de polissacarídeo
BR112018067636A2 (pt) composição fertilizante revestida por pulverização
BRPI1007724A2 (pt) Composição de revestimento seco, suspensão aquosa, substrato oral, método para preparação de dispersão aquosa de revestimento, forma de dosagem oral farmaceuticamente aceitável e método de preparação de formas de dosagem sólidas orais farmaceuticamente aceitáveis
BR112015000692A2 (pt) grânulo dispersível em água, e, método de produção do grânulo dispersível em água
BR112013003936A2 (pt) dispositivos e métodos para fornecimento intravaginal de medicamentos e outras substâncias

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/10/2013, OBSERVADAS AS CONDICOES LEGAIS